Pharmacokinetic properties of insulin degludec in healthy Chinese subjects

Journal Title: UNKNOWN - Year 2019, Vol 9, Issue 1

Abstract

Objective: The objective of this study was to investigate the pharmacokinetic properties of insulin degludec in healthy Chinese subjects and to compare those properties with results from previous trials in Caucasian and Japanese subjects. Methods: Twenty-four healthy Chinese subjects received a single dose of 0.4 U/kg body weight insulin degludec. Blood samples were taken for pharmacokinetic analysis pre-dose and until 120 hours post-dose. A population pharmacokinetic model was applied to the single-dose data to simulate steady-state profiles. Results: Compared with the observed single-dose 24-hour serum insulin degludec profile, corresponding to the first dosing interval in a once-daily regimen, the simulated steady-state serum insulin degludec concentration was higher. This was expected since steady-state for insulin degludec is reached after 2-3 days of once-daily dosing due to its long half-life. The simulated steady-state pharmacokinetic profile of insulin degludec in healthy Chinese subjects showed a close to even distribution of exposure across a 24-hour dosing interval, comparable to that in healthy Caucasian subjects and in Caucasian and Japanese subjects with type 1 diabetes. Steady-state total exposure and maximum concentration of insulin degludec were within the same range in Chinese subjects compared with Caucasian and Japanese subjects. Conclusion: The pharmacokinetic properties of insulin degludec in Chinese subjects are consistent with those in Caucasian and Japanese subjects. ClinicalTrials.gov identifier: NCT01437592.

Authors and Affiliations

Pei Hu, Ji Jiang, Lars Bardtrum, Hanne L Haahr

Keywords

Related Articles

Relationship of body mass index with diabetes and breast cancer biomarkers

Body mass index (BMI=Weight(kg)/Height(m2) is generally computed for each patient under some clinical studies, considering that it may be related with the disease. The report has derived the effects of BMI on diabetes &...

Evaluating a dietary pattern in adolescents with type 1 diabetes mellitus: The dash-d approach

Objective: Adolescents with type 1 diabetes (T1DM) must consider multiple factors in diet planning, including glycemic control and cardiovascular disease prevention, while ensuring adequate nutrition for growth. We exami...

Examining health literacy and healthy lifestyle characteristics as associated with glycemic control among community-dwelling Japanese people

Background: Diabetes mellitus (DM) is strongly associated with long-term micro- and macrovascular complications, necessitating improved glycemic control in order to reduce these complications as well as morbidity and mor...

Pharmacokinetic properties of insulin degludec in healthy Chinese subjects

Objective: The objective of this study was to investigate the pharmacokinetic properties of insulin degludec in healthy Chinese subjects and to compare those properties with results from previous trials in Caucasian and...

A clinician's guide to inpatient low carbohydrate diets for remission of type 2 diabetes : toward a standard of care protocol

Type 2 diabetes (T2DM) is most often treated as a chronic progressive condition. However, both clinical experience and scientific studies have shown that remission indicated by a normalizing of blood glucose levels and s...

Download PDF file
  • EP ID EP616118
  • DOI -
  • Views 30
  • Downloads 0

How To Cite

Pei Hu, Ji Jiang, Lars Bardtrum, Hanne L Haahr (2019). Pharmacokinetic properties of insulin degludec in healthy Chinese subjects. UNKNOWN, 9(1), 20-27. https://europub.co.uk/articles/-A-616118